FIELD: medicine, prophylaxis. SUBSTANCE: invention deals with treating and preventing diseases caused by disorders of immunological functions. Erythropoietin is suggested to be used as the above-mentioned preparation. It is more efficient against well-known analogs, has got no contraindications and is of narrow specialized action to avoid side effects. EFFECT: higher efficiency of therapy and prophylaxis. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION WITH CYTOKINE AND IMMUNOMODULATING EFFECTS | 2002 |
|
RU2222345C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEUROLOGIC DISEASES | 2007 |
|
RU2335296C1 |
PHARMACEUTICAL COMPOSITION STIMULATING IMMUNE RESPONSE OF LIVING BODY | 2021 |
|
RU2821633C1 |
METHOD OF TREATMENT OF AUTOIMMUNE GENERAL DISEASES AND MEDICAL PRODUCT | 2007 |
|
RU2361588C2 |
THERAPEUTIC AGENT CONTAINING COMBINATION OF ACTIVE SUBSTANCES CONTAINING PANTOTHENIC ACID OR ITS DERIVATIVES FOR TREATING ALLERGIC SYMPTOMS | 2008 |
|
RU2472499C2 |
HYPOALLERGENIC MEDICINAL AGENT APPLIED FOR TREATMENT OF INFECTION-INFLAMMATORY DISEASES OF DIFFERENT AETIOLOGY | 2007 |
|
RU2326688C1 |
METHOD OF MEDICINAL PREPARATIONS SCREENING | 1999 |
|
RU2150700C1 |
IMMUNOMODULATING PREPARATION | 2006 |
|
RU2294209C1 |
METHOD OF TREATING PATIENTS SUFFERING FROM COMPLICATED FORMS OF ERYSIPELAS | 2014 |
|
RU2546039C1 |
TOPICAL AND EXTERNAL TILORONE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF PURULENT-DESTRUCTIVE MUCOSAL AND SKIN DISEASES, SYSTEMIC DISEASES IN IMMUNODEFICIENCY STATES | 2008 |
|
RU2401104C2 |
Authors
Dates
2003-02-10—Published
2001-03-23—Filed